TCM directional drug penetration therapy accelerates gastrointestinal function recovery, modulates gut microbiota, and improves sleep quality in postoperative ovarian cancer patients.
In a randomized controlled trial of 112 postoperative ovarian cancer patients, those receiving TCM directional drug penetration therapy in addition to conventional rehabilitation showed significantly shorter recovery times to first bowel sounds, anal flatus, and defecation compared to controls (P < 0.05). The therapy also led to significantly lower total PSQI scores, sleep duration, sleep efficiency, and sleep disturbance scores (P < 0.05), indicating improved sleep quality. Gut microbiota analysis revealed different dominant bacteria and lower abundance of the phosphotransferase system pathway in the treatment group.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
TCM directional drug penetration therapy accelerates gastrointestinal function recovery, modulates gut microbiota, and improves sleep quality in postoperative ovarian cancer patients. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
TCM directional drug penetration therapy accelerates gastrointestinal function recovery, modulates gut microbiota, and improves sleep quality in postoperative ovarian cancer patients.
This conclusion is most relevant to: Postoperative ovarian cancer patients (n=112, 56 per group)..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effects of traditional Chinese medicine directional drug penetration therapy on gastrointestinal function, gut microbiota, and sleep quality in postoperative ovarian cancer patients: a randomized controlled trial. (Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026) —
How It Works
The proposed biological pathway:
- ▸TCM directional drug penetration therapy delivers herbal compounds transdermally to the abdominal area.
- ▸The therapy may stimulate gastrointestinal motility and reduce postoperative ileus.
- ▸It modulates gut microbiota composition, increasing beneficial bacteria (e.g., Veillonellales-Selenomonadales, Megasphaera, Corynebacterium) and decreasing Gardnerella.
- ▸The altered microbiota and reduced phosphotransferase system pathway activity may contribute to improved metabolic and inflammatory status, thereby enhancing sleep quality.
Who Might Benefit
Evidence fit by population:
- ▸Postoperative ovarian cancer patients (n=112, 56 per group).
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸The abstract does not report effect sizes or confidence intervals, limiting quantitative interpretation.
- ▸The mechanism of action is speculative; the study does not directly measure causal pathways.
- ▸The duration of follow-up is not specified, so long-term sustainability of effects is unknown.
- ▸The study is single-center and may not be generalizable to other populations or settings.
Frequently Asked Questions
What is TCM directional drug penetration therapy?▼
It is a traditional Chinese medicine technique that delivers herbal drugs through the skin to a targeted area, often used to enhance local and systemic effects.
How does this therapy affect sleep quality in postoperative ovarian cancer patients?▼
The therapy significantly reduced PSQI scores, particularly sleep duration, sleep efficiency, and sleep disturbance, indicating better sleep quality compared to conventional care alone.
What changes in gut microbiota were observed?▼
The treatment group had higher abundance of Veillonellales-Selenomonadales, Megasphaera, and Corynebacterium, while the control group had more Gardnerella. The treatment also reduced the phosphotransferase system pathway gene abundance.
Is this therapy safe for all postoperative ovarian cancer patients?▼
The abstract does not report adverse events or safety data, so safety cannot be fully assessed. Patients should consult their healthcare provider before use.
References
- 1.Wu X, Wang W. “Effects of traditional Chinese medicine directional drug penetration therapy on gastrointestinal function, gut microbiota, and sleep quality in postoperative ovarian cancer patients: a randomized controlled trial..” Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. PMID: 42616157 DOI: 10.1007/s00520-026-11096-w